azides has been researched along with vorinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breslow, R; Cornish, V; Erdjument-Bromage, H; Marks, PA; Ngo, L; Richon, VM; Rifkind, RA; Stahl, J; Tempst, P; Webb, Y; Zhou, X | 1 |
| Friedman Ohana, R; Hurst, R; Kirkland, TA; Levin, S; Machleidt, T; Rosenblatt, MM; Wood, KV; Zimmerman, K | 1 |
2 other study(ies) available for azides and vorinostat
| Article | Year |
|---|---|
Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents.
Topics: Affinity Labels; Animals; Azides; Cell Differentiation; Cell Division; Enzyme Inhibitors; Hydroxamic Acids; Mass Spectrometry; Mice; Models, Chemical; Photochemistry; Ribosomal Proteins; Tumor Cells, Cultured; Vorinostat | 1999 |
Streamlined Target Deconvolution Approach Utilizing a Single Photoreactive Chloroalkane Capture Tag.
Topics: Affinity Labels; Azides; Chromatography, Liquid; Cross-Linking Reagents; Dasatinib; Diazomethane; Histone Deacetylases; Humans; Hydrocarbons, Chlorinated; Hydrolases; K562 Cells; Mass Spectrometry; Propranolol; Protein Kinases; Proteomics; Receptors, Adrenergic, alpha-2; Ultraviolet Rays; Vorinostat | 2021 |